Echo Therapeutics Suspends Operations to Conserve Liquidity

PHILADELPHIA (Sept. 23, 2014)—Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company, announced that, as it believes that its current liquidity is insufficient to fund its needs beyond Sept. 30, 2014, it has suspended product development, research, manufacturing and clinical programs and operations to conserve liquidity and capital resources.